Clinical Trial Update: Lobectomy and Mediastinal Radiochemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer Responding to Induction Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating lobectomy after induction chemotherapy and mediastinal radiochemotherapy in unresectable stage III non-small cell lung cancer; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: European Lung Cancer Working Party | Conditions: Non Small Cell Lung Carcinoma | Phase 2 | Status: TERMINATED